Stryker Corporation (SYK) vs. Its Competitors Head to Head Contrast
Stryker Corporation (NYSE: SYK) is one of 19 public companies in the “Medical Devices & Implants” industry, but how does it compare to its competitors? We will compare Stryker Corporation to similar companies based on the strength of its earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.
Stryker Corporation pays an annual dividend of $1.70 per share and has a dividend yield of 1.1%. Stryker Corporation pays out 36.2% of its earnings in the form of a dividend. As a group, “Medical Devices & Implants” companies pay a dividend yield of 1.3% and pay out 39.8% of their earnings in the form of a dividend. Stryker Corporation has raised its dividend for 6 consecutive years.
Volatility and Risk
Stryker Corporation has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, Stryker Corporation’s competitors have a beta of 0.36, suggesting that their average share price is 64% less volatile than the S&P 500.
Earnings and Valuation
This table compares Stryker Corporation and its competitors revenue, earnings per share and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Stryker Corporation||$11.33 billion||$1.65 billion||33.36|
|Stryker Corporation Competitors||$1.67 billion||$207.58 million||55.52|
Stryker Corporation has higher revenue and earnings than its competitors. Stryker Corporation is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of current recommendations for Stryker Corporation and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Stryker Corporation Competitors||109||727||1023||10||2.50|
Stryker Corporation currently has a consensus price target of $152.37, indicating a potential downside of 2.63%. As a group, “Medical Devices & Implants” companies have a potential upside of 39.40%. Given Stryker Corporation’s competitors stronger consensus rating and higher possible upside, analysts plainly believe Stryker Corporation has less favorable growth aspects than its competitors.
This table compares Stryker Corporation and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Stryker Corporation Competitors||-101.83%||-92.87%||-30.39%|
Institutional & Insider Ownership
74.2% of Stryker Corporation shares are owned by institutional investors. Comparatively, 42.4% of shares of all “Medical Devices & Implants” companies are owned by institutional investors. 7.4% of Stryker Corporation shares are owned by insiders. Comparatively, 9.6% of shares of all “Medical Devices & Implants” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Stryker Corporation beats its competitors on 9 of the 15 factors compared.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company’s products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.